The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer
CompletedOBSERVATIONAL
Enrollment
45
Participants
Timeline
Start Date
June 2, 2024
Primary Completion Date
February 20, 2025
Study Completion Date
February 28, 2025
Conditions
Prostate Cancer Metastatic DiseasePET / CT
Trial Locations (1)
510080
First affiliated hospital, Sun Yat-sen univeristy, Guangzhou
All Listed Sponsors
lead
Sun Yat-sen University
OTHER
NCT06915714 - The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer | Biotech Hunter | Biotech Hunter